Home
Conditions
Leukemia, Lymphoid

Clinical trial condition

Leukemia, Lymphoid

Explore clinical trials studying Leukemia, Lymphoid. Study availability and eligibility vary by location and protocol.

3,020 public trials 549 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Lymphoid trial results

Completed

mHealth Family Self-Management

NCT03533049

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Completed

Evaluate the Neuroprotective Effect of Vitamin B6 and Vitamin B12 Against Vincristine Induced Neurotoxicity in Acute Lymphoblastic Leukaemia Patients

NCT03593304

Conditions: Acute Lymphoblastic Leukaemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Bangabandhu Sheikh Mujib Medical University Dhaka, Shahbag, Bangladesh

Dhaka Medical College Hospital Dhaka, Bangladesh

View Trial Details

Completed

Nutrition and Body Composition in Acute Lymphoblastic Leukemia

NCT01317940

Conditions: Avitaminosis, Body Weight, Deficiency Diseases, +20 more
Locations: Children's Hospital Los Angeles Los Angeles, California, United States

View Trial Details

Completed

P3 Study of Umbilical Cord Blood Cells Expanded With MPCs for Transplantation in Patients With Hematologic Malignancies

NCT01854567

Conditions: Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Hematologic Diseases, +17 more
Locations: University of Miami Health System Sylvester Comprehensive Cancer Center Miami, Florida, United States

Moffitt Cancer Center Tampa, Florida, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Imprime PGG, Alemtuzumab, and Rituximab in Treating Patients With High Risk Chronic Lymphocytic Leukemia

NCT01269385

Conditions: B-cell Chronic Lymphocytic Leukemia, Chronic Disease, Disease Attributes, +18 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine-Cyclophosphamide Combination in Relapsed Subjects With Chronic Lymphocytic Leukemia

NCT00824265

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more
Locations: Novartis Investigative Site Boca Raton, Florida, United States

Novartis Investigative Site Chicago, Illinois, United States

Novartis Investigative Site Clinton, Maryland, United States

Novartis Investigative Site Kansas City, Missouri, United States

View all 135 locations

View Trial Details

Completed

Sequential Regimen of Bendamustin-Debulking Followed by Ofatumumab and Ibrutinib in CLL Patients (CLL2-BIO)

NCT02689141

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: German CLL Study Group Cologne, Germany

View Trial Details

Completed

Clinical Trial of BP1001 (L-Grb-2 Antisense Oligonucleotide) in CML, AML, ALL & MDS

NCT01159028

Conditions: Acute Lymphoblastic Leukemia, Bone Marrow Diseases, Chronic Disease, +22 more
Locations: M. D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia

NCT02779283

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Hematologic Diseases, +12 more
Locations: OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Completed

Tolerance and Resistance to Ibrutinib in Patients With Chronic Lymphocytic Leukemia (CLL

NCT03502876

Conditions: B Cell Chronic Lymphocytic Leukemia, Chronic Disease, Disease Attributes, +14 more
Locations: FILO French Innovative Leukemia Organization Tours, France

Project manager Tours, France

View Trial Details

Leukemia, Lymphoid

Leukemia, Lymphoid trial results

Related conditions